Sie suchten nach: neutralizing (Englisch - Maltesisch)

neutralizing agents, antioxidants and preservatives:
aġenti newtralizzanti, anti-ossidanti u preservanti:

(optional neutralizing and buffering agents)
(l-aĠenti newtralizzanti u li jservu biex inaqqsu l-qawwa, mhux mandatorji)

neutralizing antibodies against ipilimumab were not detected.
antikorpi newtralizzanti kontra ipilimumab ma ġewx osservati.

activated partial thromboplastin time prolonged, neutralizing antibody positive
thromboplastin parzjali fuq tul ta’ żmien attivata, in-newtralizzar tal- antikorp f’pożittiv

neutralizing antibodies were detected in 19 of 299 patients in study 1.
antikorpi li jinnewtralizzaw kienu rilevati f’19 minn 299 pazjent fl-istudju 1.

there were no patients with neutralizing antibodies 2 years following treatment.
ma kien hemm l-ebda pazjenti b’antikorpi newtralizzanti sentejn wara t-trattament.

the overall neutralizing antibody rate was 26/107 patients (24%).
ir-rata totali ta’ antikorpi newtralizzanti kienet 26/107 pazjenti (24%).

this assay measures antibodies against a single neutralizing epitope for each individual hpv type.
dan l- assaġġ ikejjel l-anti-korpi kontra epitopu newtralizzanti wieħed għal kull tip individwali ta’ hpv.

1/100 (1%) ahus patients had low positive values for neutralizing antibodies.
1/100 (1%) ta’ pazjenti b’ahus kellhom valuri pożittivi baxxi għal antikorpi li jinnewtralizzaw.

samples with confirmed binding activity to ctla-4 were assessed for the presence of neutralizing antibodies.
kampjuni li ġew ikkonfermati li għandhom attività li jingħaqdu ma’ ctla-4 ġew ivvalutati għall- preżenza ta’ antikorpi newtralizzanti.

table 12: seroconversion rates and geometric mean titer of jev neutralizing antibody by vaccine dose and age group.
tabella 12: rati ta’ serokonverżjoni u titers ġeometriċi medji ta’ antikorp newtralizzanti ta’ jev bid-doża ta’ tilqim u l-grupp t’età.

1gmnu = geometric mean of neutralizing units induced in guinea pigs after twice immunisation with 0.5 ml of this vaccine
1gmnu = geometric mean of neutralizing units indott fil-fenek ta’ l-indi wara darbtejn ta’ immunizzazzjoni bi 0.5 ml ta’ dan il-vaċċin.

neutralizing anti-trastuzumab antibodies were detected in post-baseline samples in 2 of 24 herceptin intravenous patients.
antikorpi newtralizzanti kontra trastuzumab kienu osservati f’kampjuni ta’ wara l-linja bażi fi 2 minn 24 pazjent li ngħataw herceptin fil-vini.

development of non-neutralizing antibodies to the recombinant human hyaluronidase component has been reported in patients receiving hyqvia in clinical studies.
Żvilupp ta’ antikorpi mhux newtralizzanti għall-komponent ta’ hyaluronidase umana rikombinanti ġie rrappurtat f’pazjenti li kienu qed jirċievu hyqvia fl-istudji kliniċi.

within the test group, 26% of patients produced antibodies with neutralizing capacity versus 1% in the control group.
fi ħdan il- grupp tat- test, 26% tal- pazjenti ipproduċew antikorpi b' ħila newtralizzanti a paragun ta '1% fil- grupp ta' kontroll.

human normal immunoglobulin contains mainly immunoglobulin g (igg) with a broad spectrum of opsonising and neutralizing antibodies against infectious agents.
l-immunoglobulina umana normali fiha prinċipalment l-immunoglobulina g (igg) bi spettru wiesa’ ta’ opsonising u antikorpi newtralizzanti kontra aġenti infettivi.

fifty-four percent of patients tested positive for neutralizing antibodies at least once and half of the patients tested positive for neutralizing antibodies on at least three consecutive study visits.
erbgħa u ħamsin fil-mija tal-pazjenti ttestjaw pożittivi għal korpi newtralizzanti u għallinqas darba u nofs il-pazjenti ttestjaw pożittivi għal antikorpi newtralizzanti f'mill-inqas tliet żjarat konsekuttivi tal-istudju.

a neutralizing antibody to cyp2c9 showed a minimal effect on cabozantinib metabolite formation (ie, a <20% reduction).
antikorp newtralizzanti ta’ cyp2c9 wera effett minimu fuq il- formazzjoni ta’ metaboliti ta’ cabozintinib (jiġifieri, tnaqqis ta’ <20%).

no interference was observed with regards to geometric mean titer (gmt) and seroconversion rates for anti jev neutralizing antibodies (table 8).
ma ġiet osservata l-ebda interferenza fir-rigward tat-titrazzjoni ġeometrika medja (gmt) u r-rati ta’ serokonverżjoni għal antikorpi newtralizzati kontra l-jev (tabella 8).

activity-neutralizing antibodies (inhibitors) are an uncommon event in patients who have received previous treatment with factor ix-containing products.
l-antikorpi li jinnewtralizzaw l-attività (inibituri) huma avveniment mhux komuni f’pazjenti li jkunu rċevew trattament preċedenti bi prodotti li fihom il-fattur ix.